ライフサイエンスコーパス: principal investigator

1 ician could participate as a local physician-principal investigator.

2 by trained researchers and confirmed by the principal investigator.

3 lands, or analysed data were shared with the principal investigator.

4 ore the age of 51, the average age of an NIH principal investigator.

5 nd regimen received had been provided by the principal investigator.

6 ross 10 708 trials, 3151 (29.2%) had a woman principal investigator.

7 ines, and inconsistencies were resolved by a principal investigator.

8 inistry of Science and Innovation with CS as principal investigator.

9 ic training and professional profiles of the principal investigators.

10 n oncologists; 37%, women; and 83%, research principal investigators.

11 cal trial ($110,869) and multimode ($59,916) principal investigators.

12 ry 1985 through March 1996 and by queries of principal investigators.

13 n binge diaries and reviewed weekly with the principal investigators.

14 ailed to all potential participants by local principal investigators.

15 most prevalent career outcome was Academia: Principal Investigator (636/2284=27.8% of alumni), follo

16 Science Foundation's recent mandate that all Principal Investigators address the broader impacts of t

17 The Virtual Lab consists of an LLM Principal Investigator agent guiding a team of LLM scien

18 l, basic, or social science faculty who were principal investigators), amount of annual income receiv

19 of Population Health, University of Oxford, Principal Investigator and Chief Executive, UK Biobank,

20 n day 1 of each treatment cycle (28 days) by principal investigator and coinvestigators at the site.

21 are described, and a survey was sent to the principal investigator and primary clinical coordinator

22 The principal investigator and study statisticians were blin

23 ed unrelated to the intervention by the site principal investigators and chief investigator.

24 were judged unrelated to treatment by local principal investigators and confirmed by the data safety

25 ts from an NCI-sponsored meeting with MBCCOP principal investigators and data from a follow-up survey

26 s was supplemented by direct contact between principal investigators and industry sponsors.

27 ent, the type of academic degree held by the principal investigator, and the awarding institute.

28 easing numbers of new agents, fewer domestic principal investigators, and more companies off-shoring

29 tes of the early studies, the names of their principal investigators, and references to a single defi

30 or leadership, academic positions, or acting principal investigators, as well as actively involved in

31 Iannis Aifantis is a principal investigator at NYU Langone Medical Center, an

32 Arkaitz Carracedo is a principal investigator at the Association for Cooperativ

33 Sarah-Maria Fendt is a principal investigator at the Flemish Institute for Biot

34 moriam of Professor Anderson de Sa Pinheiro, principal investigator at the Laboratory of Molecular Bi

35 grants awarded to first-time male and female principal investigators at top research institutions, in

36 to women and men surgeon-scientists who were principal investigators between 1995 and 2020.

37 dation (NSF) Biological Sciences Directorate principal investigators (BIO PIs), nearly 90% indicated

38 The principal investigator classified the patients previousl

39 lusively conducted basic science research as principal investigators compared with translational rese

40 Two surveys of principal investigators conducted between April 2020 and

41 nd nine other publications coauthored by the principal investigator contain at least one major untrue

42 ty among research teams, particularly, study principal investigators, could address this inequity is

43 active vs comparator group assignments) and principal investigators/data analysts (to group assignme

44 Registered on February 24, 2016 by principal investigator, Dr.

45 linical trials found that those with a woman principal investigator enrolled a higher proportion of w

46 from a management position, or naming a new principal investigator for a project.

47 dividual participant data requested from the principal investigator for each eligible trial, adjustin

48 ampling area and permission from the study's principal investigator for use of data.

49 n for the Study of Diabetes (EASD) journals; principal investigators for ADA, JDRF, and National Inst

50 The principal investigator from each eligible study was cont

51 While principal investigators garnered a mean of $410,755 in t

52 ff or including pregnant patients) varied by principal investigator gender.

53 dary analyses found that trials with a woman principal investigator had a higher proportion of women

54 A majority of principal investigators had a PhD omnia solus (57%), and

55 While pursuing laboratory research as a principal investigator, I have also been a science admin

56 Trial registration number: ISRCTN17005348, principal investigator: Ilze Maldupa, registration date:

57 in the context of the author's experience as principal investigator in a large, randomized trial on c

58 Asian Americans are principal investigators in 18.9% of National Institutes

59 centre directors, global oncology leads, and principal investigators in 36 US states and the District

60 most biomedical PhD graduates do not become Principal Investigators in academic laboratories.

61 All NIH-funded principal investigators in dermatology were categorized

62 n the context of the authors' experiences as principal investigators in the phase I/II and/or phase I

63 nior investigators into independently funded principal investigators is comparable to other mentoring

64 new laboratory members, everyone, including principal investigators, is encouraged to use a set of p

65 ants between 1964 and 2004 stratified by the principal investigators' major degrees (MD, PhD, or MD a

66 MATERIALS AND Original principal investigators obtained ethics approval for eac

67 ACUTE II, and INTERACT were provided by the principal investigator of each study.

68 Principal investigators of 5 of 6 available randomized c

69 The principal investigators of all studies that published da

70 e of death) by direct collaboration with the principal investigators of eligible trials.

71 We contacted principal investigators of stand-alone abstracts and ong

72 The principal investigators of the eligible trials provided

73 vidual participant data were provided by the principal investigators of the respective trials and col

74 Principal investigators of the trials and their funding

75 A medical diagnosis sets a principal investigator on a new path.

76 participated in our study reported becoming principal investigators on industry clinical trials prim

77 ician scientists are less likely to serve as principal investigators on mid- and later careers awards

78 ourth of the members of FASEB Societies were principal investigators on NIH research grants.

79 emic, private-sector physicians who serve as principal investigators on US clinical trials sponsored

80 Randomisation was done by principal investigators or designee at respective centre

81 y while 45% (n = 40) required them only from principal investigators or those conducting research.

82 ical researchers (OR, 1.6; 95% CI, 1.1-2.3), principal investigators (OR, 4.3; 95% CI, 2.8-7.0), facu

83 llocation, but allocation was concealed from principal investigators, participants and their guardian

84 Principal investigators, patient advocacy groups, resear

85 lacking industry sponsorship (for which the principal investigator pays the translation costs) than

86 b of a research-intensive faculty member and principal investigator (PI) as both unattainable and und

87 ose who were awarded grants with more than 1 principal investigator (PI) by querying the internal dat

88 ical Pharmacology/Micromedex), or study site principal investigator (PI) opinion-among patients recei

89 enges facing a new independent group leader, principal investigator (PI) or university lecturer are f

90 The principal investigator (PI) promotes the professional de

91 Here we report that the NCI R01 Principal Investigator (PI) workforce expanded 1.4-fold

92 viewers to know the identity of a proposal's principal investigator (PI), which opens the possibility

93 The doctoral advisor-typically the principal investigator (PI)-is often characterized as a

94 en no quantitative analysis of who becomes a principal investigator (PI).

95 While faculty-both principal investigators (PIs) and other faculty-and thei

96 In this article, we present advice to both principal investigators (PIs) and postdocs for successfu

97 stered electronic survey and focus groups of principal investigators (PIs) and project coordinators (

98 The study was conducted among principal investigators (PIs) and research coordinators

99 In particular, white principal investigators (PIs) are consistently funded at

100 ealth in the US by African-American or Black Principal Investigators (PIs) are less likely to be fund

101 less of their previous funding success, many principal investigators (PIs) encounter a funding gap in

102 udy included a national cohort of NIH-funded principal investigators (PIs) from the NIH Information f

103 System are competitively selected and led by principal investigators (PIs).

104 opment plans (MDPs) in funding decisions for principal investigators (PIs).

105 ber of grant-eligible basic-science faculty [principal investigators (PIs)] younger than 46.

106 bmitted by African American or Black ('AAB') Principal Investigators ('PIs') skewed toward a small nu

107 Surgeon-scientists (defined as principal investigators [PIs] with a Doctor of Medicine

108 Principal investigators' (PIs) data were extracted from

109 ncreased over time, and entry into Academia: Principal Investigator positions has decreased.

110 While positions in Academia (Principal Investigator, Postdoc and Other) remained the

111 Chairpersons believed that the principal investigators' previous success with residents

112 d mRNA vaccine biotechnology-on the basis of principal investigator, project title, and abstract.

113 Blood Institute-supported publications each principal investigator published in the 5 years before g

114 The principal investigator reassessed all the capsule record

115 first draft was written in April 1996 by the principal investigator (S.G.P.) after the consensus grou

116 the role of these authors rather than of the principal investigator(s) as in the previous policy.

117 The funder, principal investigators, site investigators, patients, i

118 (ie, R01-equivalent) grant and being a super principal investigator (SPI) with $750 000 or more in to

119 esearch project grants, referred to as super principal investigators (SPIs), by gender, race, and eth

120 Between 1995 and 2020, 2078 principal investigator surgeons received funding from th

121 Disagreements were reviewed with the principal investigator to reach consensus.

122 located to placebo; none were judged by site principal investigators to be related to study medicatio

123 for extensive response and redrafting by the principal investigator until all members were satisfied.

124 ial UNIP assessment were not gathered by the principal investigator until all other study procedures

125 n enrollment of women in trials with a woman principal investigator was 54.1% (95% CI, 53.0%-55.1%) c

126 95% CI, 46.3%-47.5%) for trials in which the principal investigator was a man (absolute adjusted diff

127 r, the corresponding ethics committee or the principal investigator was contacted for clarification.

128 m for interns, host/employer, and supervisor/principal investigator were assessed using a mixed-metho

129 Both the patient and the principal investigator were blinded to the nature of sur

130 TICIPANTS: Big Ten COVID-19 Cardiac Registry principal investigators were surveyed for aggregate obse

131 All eligible patients were contacted by the principal investigator who was not their physician.

132 Before randomization, each principal investigator will provide a commitment to part

133 total dollar amount of R01 grants awarded to principal investigators with only an MD degree trended d

134 Sites selected for participation were led by principal investigators with research experience, who we